Hook and thesis
Teradyne ($386.10) is at the intersection of two durable trends: exploding AI demand for memory and the steady move to higher-density, more complex chips that require more and deeper test. The market has begun to price in that opportunity after strong Q2 results, but near-term price action suggests a pullback is possible. For investors who want exposure to the test-and-automation part of the AI supply chain, I upgrade Teradyne to Buy while advising a disciplined dip-buy strategy rather than chasing the breakout.
Why this matters now: Q2 beat-and-raise momentum, the company’s inclusion in the Nasdaq-100 (effective 06/22/2026), and rising share of AI-driven revenue combine to create a multi-quarter tailwind. But valuation is rich - a PE in the mid-50s and a market cap approaching $60B - so timing matters. My recommended approach is to enter on weakness near established intraday support, use a tight stop, and target a return toward the 52-week highs if the fundamental story stays intact.
Business snapshot - what Teradyne does and why the market should care
Teradyne builds automated test systems primarily for semiconductors, plus robotics and related automation. The Semiconductor Test segment is the core - customers test wafers and packaged chips to ensure performance and yield before shipping. As chips become denser and memory architectures proliferate for AI models, testing cycles per wafer and test complexity increase straight-line demand for advanced testers. The Robotics segment provides optional diversification into automation and collaborative robots, which benefits from broader industrial automation trends.
The market cares because testing is a required step in semiconductor manufacturing. When capex goes into fabs and memory makers ramp, test equipment vendors see an outsized but tangible lift in backlog and revenue. Teradyne is reporting that a large share of revenue is now AI-related and that growth from memory and AI infrastructure is contributing materially to top-line expansion.
Key fundamental evidence
- Q2 results showed adjusted EPS of $2.47 on revenue of $1.33B, beating expectations and reinforcing the growth narrative.
- Management guided Q3 revenue to $1.2B - $1.3B and adjusted EPS $1.85 - $2.15. Consensus had been nearer $1.03B and $1.44 EPS, so guidance materially outpaced Street expectations and implies continued demand even with natural timing lumpiness.
- Public commentary indicates AI now accounts for roughly 70% of revenue, with cited year-over-year revenue growth in certain periods as high as 87% - this shows where incremental demand is concentrated.
- Balance-sheet and shareholder-return metrics: market capitalization is roughly $59.35B; free cash flow runs near $800M annually; return on equity is very healthy at ~33.5% and return on assets ~23.4%.
Valuation framing
At today’s price around $386, Teradyne trades at a PE in the mid-50s and a price-to-sales north of 14. That multiple reflects a premium for secular growth and high margins - reasonable if the company delivers several years of 40%+ top-line growth from AI and memory-related testing. On the other hand, even modest sequential softness or a pullback in capex at major memory customers would compress multiples quickly.
Looked at pragmatically: market cap near $59B versus free cash flow close to $800M implies FCF yield under 2%. That forces a high bar for multiple years of robust growth. The valuation is not grossly detached if the company can sustain elevated growth and margin leverage, but it does mean investors should prioritize entry discipline and not buy at every breakout.
Technicals and positioning
- Current price: $386.10; 52-week high $487.91, 52-week low $106.30.
- Short-term indicators mixed but slightly constructive: 50-day SMA is $385.19, 20-day SMA $377.92, 10-day SMA $396.80; RSI around 49, MACD showing bullish momentum.
- Volume and short activity show meaningful participation: recent short interest and short-volume spikes indicate there are active bears - days-to-cover figures sit around ~1.9 most recently, so squeezes can be fast but limited in runway.
Catalysts to watch (2-5)
- Quarterly earnings cadence - continued beats and raised guidance will support multiple expansion and validate the buy thesis. Next EPS prints and guidance commentary are primary catalysts.
- Memory capex announcements from major customers - capacity additions at memory suppliers or public signs of rising wafer starts translate to order flow for testers.
- New product ramps for higher-density or advanced-node testers that materially increase ASPs and attach rates.
- Institutional index flows and inclusion-related rebalancing (post 06/22/2026 Nasdaq-100 addition) can provide episodic support or pressure depending on ETF flows.
Trade idea - actionable plan
I upgrade Teradyne to Buy with a dip-entry focus. The stock is likely to remain volatile around earnings and broader market swings, so we use a mid-term swing window to capture the next meaningful leg higher if fundamentals hold.
| Action | Price | Horizon |
|---|---|---|
| Entry (limit) | $375.00 | Mid term (45 trading days) - enough time for earnings cadence or dip to resolve and for orders/backlog to show through |
| Stop loss | $355.00 | |
| Target | $470.00 |
Rationale: $375 sits just above recent intraday support and near the low seen earlier today ($374.01), which gives a concrete place to buy without chasing. A stop at $355 limits the downside if the tape signals a larger unwind of AI/memory hopes. The target at $470 is toward the 52-week high of $487.91 and achievable if orders and guidance continue to outperform expectations.
Note on horizon: I recommend mid term (45 trading days). This window captures the near-term earnings/guidance reaction and allows time for backlog and shipments to show up in results or for a catalyst (memory capex announcements) to materialize. If you prefer a longer hold for multi-quarter exposure, re-evaluate after each quarterly print and consider moving stops up on strength.
Risks and counterarguments
- Valuation shock: The PE near the mid-50s and low FCF yield mean the stock is priced for continued strong growth. Any evidence of slowing revenue or margin pressure could lead to a rapid multiple contraction.
- Customer concentration and timing risk: Orders from large memory or AI customers can be lumpy. If a major customer delays a ramp, revenue and guidance could miss and the stock could retrace sharply.
- Cycle sensitivity: Test equipment is cyclical and tied to semiconductor capex. Broader semiconductor spending weakness or a macro slowdown could reduce demand faster than current guidance implies.
- Competition and technology risk: Advances by other test-equipment vendors or a faster-than-expected move to in-line/on-chip validation could reduce addressable spending for Teradyne’s current product set.
- Market-volatility and liquidity risk: High short-volume days and active trading mean swings can be amplified; a market-wide selloff could force stop-outs even if fundamentals remain intact.
Counterargument: One coherent counter view is that Teradyne is already priced for perfection. With AI-related revenue reportedly at ~70% and sky-high multiples, any misstep in customer ramps or a temporary pause in memory capex would make the stock a crowded short candidate. That is a valid point - the valuation leaves little margin for error and justifies the dip-entry approach rather than buying at current highs.
What will change my view
- I would increase conviction if upcoming quarters deliver sustained revenue growth above guidance and FCF conversion remains strong - evidence of durable demand from multiple customers rather than a few large ramps.
- I would downgrade if management points to materially weaker customer orders, pushed-out shipments, or if GAAP/adjusted margins show persistent deterioration that can't be explained by normal timing effects.
- Broader semiconductor capex reversals or signs that AI memory demand collapses would also force a reassessment.
Bottom line
Teradyne is a high-quality play on a test-and-automation cycle driven by AI and memory growth. Earnings momentum and guidance support an upgraded Buy, but the valuation leaves limited room for execution hiccups. The practical way to own it now is with a dip-entry: buy near $375, protect at $355, and target $470 over a mid-term window (45 trading days). That plan captures upside if the AI-driven thesis continues to unfold while keeping downside risk controlled if the market re-prices the story.